Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/21/2003US20030157508 Genetic engineering; gene therapy
08/21/2003US20030157494 Smooth muscle cell promoter and uses thereof
08/21/2003US20030157476 Immortalized human keratinocyte cell line
08/21/2003US20030157475 Cryopreservation of selected sperm cells
08/21/2003US20030157474 Removal antigens from blood
08/21/2003US20030157473 Compositions comprising reproductive cell media and methods for using such compositions
08/21/2003US20030157230 Process for stabilizing proteins in an acidic environment with a high-ester pectin
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157132 Remedies for hepatitis c
08/21/2003US20030157128 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157114 Treatment of autoimmune diseases
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157102 Administering a ligand having a population of activated t cells and binding specificity for the extracellular domain of CD28 to enhance t cell proliferation and increase overall lymphokine levels
08/21/2003US20030157100 Monoclonal antibody inducing apoptosis
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157095 Invasive and metastic ability of breast cancer cells is proportional to level of peripheral type benzodiazepine receptor expressed, correlates with subcellular localization in that it is found in the nucleus of aggressive tumor cells
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157078 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
08/21/2003US20030157077 Induction of chimera mixture; anticancer agents, leukemia
08/21/2003US20030157076 Disruption of the Akt2 gene
08/21/2003US20030157074 Vitro micro-organs, and uses related thereto
08/21/2003US20030157071 Hormone replacement therapy; transduction bone marrow cells; cell differentiation
08/21/2003US20030157070 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
08/21/2003US20030157069 Administering polypeptide; them radiation and drug therapy
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003US20030157063 Infection therapy; viricides; gene therapy; immunoglobulins
08/21/2003US20030157060 Production of tcr gamma delta t cells
08/21/2003US20030157057 Antiinflammatory agents, antitumor agents, autoimmune disease
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003US20030154729 Cryogenic preservation of biological material by circulating a cooling fluid
08/21/2003CA2492097A1 Signal for packaging of influenza virus vectors
08/21/2003CA2476553A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476232A1 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003CA2475929A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475356A1 Human fetal bladder-derived epithelial cells
08/21/2003CA2475348A1 Systems and methods for rapidly changing the solution environment around sensors
08/21/2003CA2475177A1 Materials and methods for preparing dimeric growth factors
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2474364A1 Functionalization of carotenoid compounds
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336846A1 Method for generating recombinant human platelets for identifying therapeutic target proteins
08/20/2003EP1336652A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
08/20/2003EP1336109A1 Kit and method for detecting the esm-1 protein
08/20/2003EP1336088A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335972A2 Tolerizing allografts of pluripotent stem cells
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335934A1 Gene encoding protein cluster i and the encoded protein
08/20/2003EP1335735A1 Vascularised tissue graft
08/20/2003EP1147213A4 Novel rgs-containing molecules and uses thereof
08/20/2003EP1093381B1 Antigenic peptides derived from telomerase
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP1027589B1 Device and method for the separation of human or animal cells of different densities from cellular dispersions which contain them
08/20/2003EP0946127B1 Biopolymer foams for use in tissue repair and reconstruction
08/20/2003EP0879414B1 Method for evaluating keratinocyte migration
08/20/2003EP0868511B1 Utrophin gene expression
08/20/2003EP0865288B1 Bioartificial devices and cellular matrices therefor
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1436845A Stress resistance plant with introduced cell death inhibiting gene and process for producing the same plant
08/20/2003CN1436844A Insulin resisting cell and its transformation process and application
08/20/2003CN1436843A Making process of umbilical hemopoietic stem cell
08/20/2003CN1118578C Method of producing taxad alkane by using Chinese yew cell
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118569C (-)-strand RNA virus vector having autonomously replicating activity
08/20/2003CN1118568C Anti P185 neu/c-erb B-2 monoclonal anti-body hybridoma, prepn. method therefor, use as tumor detection
08/20/2003CN1118567C Medusa-snow lotus high output flavone cell line
08/20/2003CN1118566C Tissue paraffin wax section dewaxing and clarifier
08/19/2003US6608241 Protection of plants against viral infection
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608180 Nucleotide sequences coding preferential protein for use cancer treatment
08/19/2003US6608178 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608038 Methods and compositions for treatment of diabetes and related conditions via gene therapy
08/19/2003US6608037 TCF responsive element
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6607917 Propagating preferential aggregates in nutrient broth; obtain aggregate, hold in preferential position, supply with nutrients, propagate aggregates, recover aggreagtes
08/19/2003US6607913 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/19/2003US6607910 Perfusion bioreactors; porous membranes; rotation; shear stress; high nutrient transfer; efficient removal of wastes or bio-products; use to allow attachment of different types of human cells to represent various tissues in human body
08/19/2003US6607883 Domains; amino acid fragments; 3'-5' exonuclease; nucleic acid synthesis; polymerase chain reaction (PCR); kits; use for production of chimeras and use of chimeras for production of nucleic acids during PCR
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607740 Enzyme-mediated modification of fivrin for tissue engineering
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003US6607720 Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction
08/19/2003US6607501 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications
08/19/2003CA2165953C Prostaglandin receptor ep3 and dna encoding it
08/19/2003CA2142819C Glucagon receptors
1 ... 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 ... 1827